Friday, November 21, 2008 - 7:56PM EST

Drug Therapy

1. The COUPLES-project: a pooled analysis of patient and partner treatment satisfaction scale (TSS) outcomes following vardenafil treatment.

Author
Rosen RC; Fisher WA; Beneke M; Homering M; Evers T;
Institution
New England Research Institutes, Watertown, MA, USA. rrosen@neriscience.com
Journal
BJU Int. 2007 Apr;99(4):849-59.
Abstract URL
Click here to view abstract

2. How long do patients with erectile dysfunction continue to use sildenafil citrate? Dropout rate from treatment course as outcome in real life.

Author
Sato Y; Tanda H; Kato S; Onishi S; Nitta T; Koroku M; Sato Y; Tanda H; Kato S; Onishi S; Nitta T; Koroku M;
Institution
Sanjukai Urological Hospital, Sapporo, Japan. ysato@sanjukai.or.jp
Journal
Int J Urol. 2007 Apr;14(4):339-42; discussion 343.
Abstract URL
Click here to view abstract

3. Improvement in erectile function on vardenafil treatment correlates with treatment satisfaction in both patients and their partners.

Author
Ralph D; Eardley I; Kell P; Dean J; Hackett G; Collins O; Edwards D;
Institution
Middlesex Hospital, London, UK.
Journal
BJU Int. 2007 May 4;.
Abstract URL
Click here to view abstract

4. Chronic sildenafil in men with diabetes and erectile dysfunction.

Author
Aversa A; Bruzziches R; Vitale C; Marazzi G; Francomano D; Barbaro G; Spera G; Rosano GM; Aversa A; Bruzziches R; Vitale C; Marazzi G; Francomano D; Barbaro G; Spera G; Rosano GM;
Institution
University of Rome La Sapienza, Dept of Medical Pathophysiology, Viale Policlinico 155 - 00161 Rome, Italy.
Journal
Expert Opin Drug Metab Toxicol. 2007 Jun;3(3):451-64.
Abstract URL
Click here to view abstract

5. Duration of erectile dysfunction and its relationship to treatment seeking and satisfaction with treatment using PDE5 inhibitors.

Author
Matic H; McCabe MP;
Institution
School of Psychology, Deakin University, Melbourne, Victoria, Australia.
Journal
Int J Urol. 2008 Apr;15(4):346-9.
Abstract URL
Click here to view abstract

6. Therapeutic effectiveness and patient satisfaction after 6 months of treatment with tadalafil, sildenafil, and vardenafil: results from the erectile dysfunction observational study (EDOS).

Author
Martin-Morales A; Haro JM; Beardsworth A; Bertsch J; Kontodimas S; Martin-Morales A; Haro JM; Beardsworth A; Bertsch J; Kontodimas S;
Institution
Hospital Carlos Haya, Servicio de Urologia, Malaga, Spain. amartinmorales@terra.es <amartinmorales@terra.es>
Journal
Eur Urol. 2007 Feb;51(2):541-50; discussion 550. Epub 2006 Oct 16.
Abstract URL
Click here to view abstract

7. Real-life safety and efficacy of vardenafil in the treatment of erectile dysfunction-results from 30,010 U.S. patients.

Author
Cheng E; Cheng E;
Institution
Department of Family Medicine, State University of New York, Health Science Center, Brooklyn, New York, USA. mrspeakerz@earthlink.net
Journal
J Sex Med. 2007 Mar;4(2):432-9. Epub 2006 Nov 6.
Abstract URL
Click here to view abstract

8. Patients responding to phosphodiesterase type 5 inhibitor therapy-what do their sexual partners know?

Author
Klotz T; Mathers M; Klotz R; Sommer F;
Institution
Department of Urology, Klinikum Weiden, Weiden, Germany.
Journal
J Sex Med. 2007 Jan;4(1):162-5. Epub 2006 Nov 6.
Abstract URL
Click here to view abstract

9. Do vardenafil and tadalafil have advantages over sildenafil in the treatment of erectile dysfunction?

Author
Doggrell S; Doggrell S;
Institution
School of Science, Charles Darwin University, Casuarina, Northern Territory, Australia. sheila.doggrell@cdu.edu.au
Journal
Int J Impot Res. 2007 May-Jun;19(3):281-95. Epub 2006 Dec 21.
Abstract URL
Click here to view abstract

10. Phosphodiesterase type 5 inhibitors: the day after.

Author
Hatzimouratidis K; Hatzichristou D;
Institution
2nd Department of Urology, Papageorgiou General Hospital and Center for Sexual and Reproductive Health, Aristotle University of Thessaloniki, Greece.
Journal
Eur Urol. 2007 Jan;51(1):75-88; discussion 89. Epub 2006 Aug 1.
Abstract URL
Click here to view abstract
Pages: 1 2 3